Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis.
Year: 2009
Type: article
Source: PubMed
Authors: A J Hutchison, M E Barnett, R Krause, J, G A Siami
Institution: Manchester Royal Infirmary
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W21316660
